aTyr Pharma | LIFE - Debt


aTyr Pharma reported $1.84M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Ardelyx USD 207.61M 968K Sep/2025
aTyr Pharma USD 1.84M 8K Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Galapagos EUR 7.5M 3.36M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Grifols EUR 9.23B 626.05M Dec/2024
Novartis USD 32.64B 1.37B Jun/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
United Therapeutics USD 200M 100M Mar/2025
Xoma USD 120.79M 3.27M Jun/2024